Streetbeat News

Regulatory

FLCH

FXI

KWEB

MCHI

China is projected to surpass the US in advanced technology and military manufacturing by 2035, according to a report. This shift has implications for global geopolitics and economic balance, as China invests heavily in semiconductor manufacturing and circumvents US trade restrictions.

Portfolio Pulse from Benzinga Neuro

October 02, 2024 | 2:08 pm

SPY

The article discusses the market adage 'Sell Rosh Hashanah, Buy Yom Kippur,' which has proven successful in 2023. The SPDR S&P 500 ETF Trust (SPY) is highlighted as a key index reflecting this trend. Despite geopolitical tensions and upcoming economic data releases, the market has shown resilience. Investors are advised to consider their long-term objectives when making decisions.

Portfolio Pulse from Joel Elconin

October 02, 2024 | 1:55 pm

IMMX

Immix Biopharma has advanced its CAR-T therapy, NXC-201, to a higher dose level in its U.S. trial for AL Amyloidosis. The trial, NEXICART-2, is now dosing at 450 million CAR+T cells, following successful results at a lower dose. NXC-201 is the only one-time CAR-T treatment for this condition in U.S. trials.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:33 pm

SPY

URA

The Russian Foreign Ministry has stated that it sees no point in engaging in nuclear talks with the U.S. due to Washington's stance on NATO expansion. This development could impact geopolitical stability and influence market sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:27 pm

BABA

BIDU

JD

LI

NIO

PDD

XPEV

ZK

Chinese stocks, including Alibaba, NIO, XPeng, and Li Auto, are rallying following China's stimulus plans, which include cutting the reserve requirement ratio and allowing mortgage refinancing. Alibaba is highlighted as a key beneficiary, with increased exposure from investors like David Tepper.

Portfolio Pulse from Anusuya Lahiri

October 02, 2024 | 1:26 pm

EGRX

Eagle Pharmaceuticals will be delisted from Nasdaq on October 3, 2024, due to non-compliance with Nasdaq Listing Rule 5250(c)(1). The company failed to file required financial reports and did not appeal the delisting decision.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:20 pm

AAPL

BABA

NVDA

Jim Cramer advises investors to let 'hot money' flow out of Nvidia and Apple, suggesting potential short-term declines due to high valuations and post-iPhone slump. He recommends considering Alibaba for those looking at Chinese markets, citing its solid fundamentals despite regulatory challenges.

Portfolio Pulse from Surbhi Jain

October 02, 2024 | 1:11 pm

ZENA

ZenaTech has received FAA approval for the evaluation, testing, and demonstration of its ZenaDrone solutions in the U.S. This approval marks a significant step for ZenaTech in expanding its drone operations and market presence in the United States.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:09 pm

KSCP

Knightscope, Inc. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 1:01 pm

SOBR

Trading for SOBR was halted and then resumed, with updates provided at 8:55 AM ET. The halt was likely due to pending news or significant market activity.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:55 pm